PETER BARSCHORFF, Vice President, Deallus

•   Peter Barschdorff is Vice President and Head of the U.S. consulting business at Deallus, a global boutique pharma consultancy serving half of the world’s top-25 pharmas as well as select emerging biopharmas.

•   Peter’s experience spans more than two decades, both in management consulting and in industry senior executive positions, most recently as GSK’s U.S. Pharma Chief Analytics Officer, and member of the Pharma Executive team at Bayer U.S. Previously, he served as global Head of Complexity Reduction at Bayer, and as deputy Head of the global inhouse consulting function, which brought him to oversee consulting projects from Mexico, across the U.S., and to China.

•   He started his career in the pharmaceutical industry as an analyst in market access consulting, mainly focused on several of the world’s top blockbuster drugs of the early 2000s. His project experience ranges from the creation of pharmaco-economic models to contracting process design, from pricing to national accounts operating model improvement, and from establishment of one of the first managed care departments in biotech to devising employer strategies for big pharma.Most recently, he oversaw payer research for an innovative digital solution as well as about payer values and barriers for access to launch an innovative CAR-T therapy in U.S. market.

•   Peter originally trained as defense analyst; his Doctorate is from the Free University of Berlin (Germany) and his MBA from Columbia Business School. He has chaired a number of industry conferences, most recently the 6th Annual Pharma Pricing, Reimbursement & Market Access conference, 2022, in Boston.